Plus: South Africa’s guideline wars; AGP & the UK trial; the German ploy in Norway; French lessons; puberty blocker politics in Oz; Canada conscripts doctors; DIY hormones; Dutch queering of consent
The National Health and Medical Research Council (NHMRC) is responsible for developing medical guidelines and assessing guidelines developed by other institutions.
Three examples:
1. Stroke and cardiovascular care
2. Cancer screening and prevention
3. Preventive health and immunisation
Over the past 25 years thousands of Australian children and adolescents have undergone a medical intervention involving non-standard hormone therapies and, at times, followed by genital mutilation and permanent sterility.
This intervention had not undergone a formal clinical trial to confirm safety and efficacy and
I can find no evidence that the Royal Children’s Hospital (RCH) ever requested the NHMRC to assess, approve, endorse, or provide a formal opinion on the ‘Affirmative Model of Gender Care’
in 2022 When the RCH gender clinics ‘Australian Standards of Care and Treatment Guidelines’ were submitted to be posted on the NHMRC online portal for the Australian Clinical Practice Guidelines the NHMRC refused to include them as they failed to meet ‘the basic portal selection criteria’.
If this is the case it would imply a level of irresponsibility in ignoring the inbuilt safety mechanisms of the NMHRC that was readily accessible within the health system.
Failure to access a source of high-quality critique in such a complex issue implies a level of self-assurance that is inappropriate.
Finally, In January 2025 the Federal Health Minister requested the NHMRC to develop guidelines for the treatment of Gender Dysphoria, with the result expected in three years.
…. 25 years is a very long time to decide on the safety and efficacy of such high-stakes intervention involving children.
Where did you hear that the NHMRC report will now come out in October? And are you sure that it will? After all, they originally said it would come out in August and then it didn’t…
The National Health and Medical Research Council (NHMRC) is responsible for developing medical guidelines and assessing guidelines developed by other institutions.
Three examples:
1. Stroke and cardiovascular care
2. Cancer screening and prevention
3. Preventive health and immunisation
Over the past 25 years thousands of Australian children and adolescents have undergone a medical intervention involving non-standard hormone therapies and, at times, followed by genital mutilation and permanent sterility.
This intervention had not undergone a formal clinical trial to confirm safety and efficacy and
I can find no evidence that the Royal Children’s Hospital (RCH) ever requested the NHMRC to assess, approve, endorse, or provide a formal opinion on the ‘Affirmative Model of Gender Care’
in 2022 When the RCH gender clinics ‘Australian Standards of Care and Treatment Guidelines’ were submitted to be posted on the NHMRC online portal for the Australian Clinical Practice Guidelines the NHMRC refused to include them as they failed to meet ‘the basic portal selection criteria’.
If this is the case it would imply a level of irresponsibility in ignoring the inbuilt safety mechanisms of the NMHRC that was readily accessible within the health system.
Failure to access a source of high-quality critique in such a complex issue implies a level of self-assurance that is inappropriate.
Finally, In January 2025 the Federal Health Minister requested the NHMRC to develop guidelines for the treatment of Gender Dysphoria, with the result expected in three years.
…. 25 years is a very long time to decide on the safety and efficacy of such high-stakes intervention involving children.
Where did you hear that the NHMRC report will now come out in October? And are you sure that it will? After all, they originally said it would come out in August and then it didn’t…
True, it was supposed to come mid-year. Now we're told it will come in October, though you can't rule out further delays.
https://www.nhmrc.gov.au/health-advice/guidelines-care-trans-and-gender-diverse-people/guideline-development